| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
ACE AVIATION SERVICE is a Oceanside, CA-based company in the Business Services sector.
Show Hope was founded by Mary Beth and Steven Curtis Chapman and works to break down barriers that exist between waiting children and loving families.
Dekalb Metal Finishing is a Auburn, IN-based company in the Business Services sector.
Specialty Tool Inc is a Fort Wayne, IN-based company in the Business Services sector.